Antidiabetic and antihyperlipidaemic activity of ethanol extract of Melastoma malabathricum Linn. leaf in alloxan induced diabetic rats

Karuppasamy Balamurugan; Antony Nishanthini; Veerabahu Ramasamy Mohan

doi:10.12980/APJTB.4.2014C122

. 2014 May;4(Suppl 1):S442–S448. doi: 10.12980/APJTB.4.2014C122

Antidiabetic and antihyperlipidaemic activity of ethanol extract of Melastoma malabathricum Linn. leaf in alloxan induced diabetic rats

Karuppasamy Balamurugan ^1,², Antony Nishanthini ^1,², Veerabahu Ramasamy Mohan ^1,^2,^*

Reviewed by: K Arumugasamy^1,²

PMCID: PMC4025341 PMID: 25183126

Abstract

Objective

To evaluate the antidiabetic and antihyperlipidaemic effect of ethanol extract of Melastoma malabathricum (M. malabathricum) Linn. leaf in alloxan induced diabetic rats.

Methods

Diabetes was induced in albino rats by administration of alloxan monohydrate (150 mg/kg i.p). the ethanol extracts of M. malabathricum at a dose of 150 and 300 mg/kg of body weight were administrated at a single dose per day to diabetes induced rats for a period of 14 d. The effect of ethanol extract of M. malabathricum leaf extract on blood glucose, plasma insulin, creatinine, glycosylated haemoglobin, urea serum lipid profile [total cholesterol, triglycerides, low density lipoprotein-cholesterol, very low density lipoprotein-cholesterol, high density lipoprotein-cholesterol and phospholipid, serum protein, albumin, globulin, serum enzymes (serum glutamate pyruvate transaminases), serum glutamate oxaloacetate transaminases, and alkaline phosphatase] were measured in the diabetic rats.

Results

In the acute toxicity study, ethanol extract of M. malabathricum leaf was non-toxic at 2 000 mg/kg in rats. The increased body weight, decreased blood glucose, glycosylated haemoglobin and other biochemical parameters level were observed in diabetic rats treated with both doses of ethanol extract of M. malabathricum leaf compared to diabetic control rats. In diabetic rats, ethanol extract of M. malabathricum leaf administration, altered lipid profiles were reversed to near normal than diabetic control rats.

Conclusions

Ethanol extract of M. malabathricum leaf possesses significant antidiabetic and antihyperlipidaemic activity in diabetic rats.

Keywords: Melastoma malabathricum, Antidiabetic, Antihyperlipidaemic, Alloxan, Glibenclamide, SGOT, SGPT, HbA1c

1. Introduction

Diabetes mellitus is an epidemic occurring in adults throughout the world and is the leading cause of kidney failure, heart attack, blindness and lower limb amputation. It is the fourth main cause of death in most developed countries. The prevalence of diabetes is estimated to reach 330 million by the year 2025, according to International Diabetes Federation, with the greatest potential increase being in Africa and Asia. This numerical increase will occur in developing countries. By the year 2025, over 75% of people with diabetes will reside in developing countries, as compared to 62% in 1995[1].

Currently available therapies for diabetes include insulin and various oral antidiabetic agents such as sulfonylureas, biguanides and glinides. Many of them have a number of serious adverse effects; therefore, the search for more effective and safer hypoglycemic agents is one of the important areas of investigations[2]. Many herbs and plants have been described as possessing hypoglycemic activity when taken orally[3]. According to the World Health Organization, there are more than 1 200 plant species worldwide used in the treatment of diabetes mellitus and substantial number of plant showed effective hypoglycemic activity after laboratory testing[4].

Recently, some medicinal plants have been reported to be useful in diabetes worldwide and have been used empirically in antidiabetic and antihyperlipidemic remedies. Antihyperglycemic activity of the plants is mainly due to their ability to restore the function of pancreatic tissues by causing an increase in insulin output or inhibiting the intestinal absorption of glucose or to the facilitation of metabolites in insulin dependent processes. More than 400 plant species having hypoglycemic activity have been available in literature, however, searching for new antidiabetic drugs from natural plants is still attractive because they contain substances which demonstrate alternative and safe effects on diabetes mellitus. Most of the plants contain glycosides, alkaloids, terpenoids, flavonoids, carotenoids etc. that are frequently implicated as having antidiabetic effect[5]. However, the study of plant for hypoglycemic, antioxidant and hypolipidemic activities may give new pharmacological approaches in the treatment of diabetes mellitus[6].

Melastoma malabathricum (M. malabathricum) Linn. belongs to the Melastomataceae family. It is also called the Singapore Rhododendron or Sendudok. It is an erect shrub or small tree with the height of 1.5 to 5 m. It was traditionally used to treat diarrhoea, dysentery, leucorrhoea, hemorrhoids, wounds, infection during confinement, toothache, flatulence, sore legs, and thrush and it is also used by the Jah hut people in Malaysia to cure diarrhea[7]. There is no report on the antidiabetic and antihyperlipidaemic potential of this plant extract so far. The main objective of this study was to assess the antidiabetic and antihyperlipidaemic effect of ethanol extracts of leaf of M. malabathricum in alloxan induced diabetic rats.

2. Materials and methods

2.1. Plant material

The leaves of M. malabathricum were freshly collected from Daudeli, Joide Taluk, Hubli district, North Karnataka. With the help of local flora, a voucher specimen was retained in Ethnopharmacology Unit, Research Department of Botany, V. O. Chidambaram College, Tuticorin for further reference.

2.2. Preparation of plant extract for phytochemical screening and antidiabetic studies

The M. malabathricum leaf was shade dried at room temperature and the dried leaf was powdered in a Wiley mill. Hundred grams of powdered leaf was packed in a Soxhlet apparatus and extracted with ethanol. The extracts were subjected to qualitative test for the identification of various phytochemical constituents as per the standard procedures[8],[9]. The ethanol extracts were concentrated in a rotary evaporator. The concentrated ethanol extracts were used for antidiabetic studies.

2.3. Animals

Normal healthy male Wistar albino rats (180-240 g) were housed under standard environmental conditions at temperature (25±2) °C and light and dark (12:12 h). Rats were fed with standard pellet diet (Goldmohur brand, MS Hindustan lever Ltd., Mumbai, India) and water ad libitum. Study was carried out as per IAFC approval No: 82/PHARMA/SCRI, 2010.

2.4. Acute toxicity study

Acute oral toxicity study was performed as per Organization for Economic Co-operation and Development-423 guidelines (acute toxic class method), albino rats (n=6) of either sex selected by random sampling were used for acute toxicity study[10]. The animals were kept fasting for overnight and provided only with water, after which the extracts were administered orally at 5 mg/kg body weight by gastric intubations and observed for 14 d. If mortality was observed in two out of three animals, then the dose administered was assigned as toxic dose. If mortality was observed in one animal, then the same dose was repeated again to confirm the toxic dose. If mortality was not observed, the procedure was repeated for higher doses such as 50, 100, and 2 000 mg/kg body weight.

2.5. Induction of diabetes in experimental animal

Rats were induced diabetes by the administration of simple intraperitoneal dose of alloxan monohydrate (150 mg/kg)[11]. After 2 d of alloxan injection, rats screened for diabetes having glycosuria and hypoglycemia with blood glucose level of 200-260 mg/100 mL were taken for the study. All animals were allowed free access to water and pellet diet and maintained at room temperature in plastic cages.

2.6. Experimental design

In the present investigation, a total of 30 rats (24 diabetic surviving rats and six normal rats) were taken and divided into five groups of six rats each. Group I: normal untreated rats; Group II: diabetic control rats; Group III: diabetic rats given ethanol extract of M. malabathricum leaf (150 mg/kg body weight); Group IV: diabetic rats given ethanol extract of M. malabathricum leaf (300 mg/kg body weight); Group V: diabetic rats given standard drug glibenclamide (600 µg/kg body weight).

The animals were sacrificed at the end of experimental period of 14 d by decapitation. Blood was collected, sera separated by centrifugation at 3 000 g for 10 min.

2.6.1. Estimation of insulin, glucose, urea, creatinine and glycosylated haemoglobin

Serum glucose was measured by the o-toluidine method[12]. Insulin level was assayed by ELISA kit[13]. Urea estimation was carried out by the method of Varley[14]; serum creatinine was estimated by the method of Owen et al[15]. Glycosylated haemoglobin (HbA1c) estimation was carried out by a modified colorimetric method of Karunanayake and Chandrasekharan[16].

2.6.2. Estimation of protein, albumin, globulin, SGPT, SGOT, ALP

Serum protein[17] and serum albumins were determined by quantitative colorimetrically method by using bromocresol green. The total protein minus the albumin gives the globulin, serum glutamate pyruvate transaminase (SGPT) and serum glutamate oxaloacetate transaminase (SGOT) was measured spectrophotometrically by utilizing the method of Reitman and Frankel[18]. Serum alkaline phosphatase (ALP) was measured by the method of King and Armstrong[19].

2.6.3. Estimation of lipids and lipoprotein

Serum total cholesterol (TC)[20], total triglycerides (TG)[21], low density lipoprotein cholesterol (LDL-C), very low density lipoprotein cholesterol (VLDL-C)[22], high density lipoprotein cholesterol (HDL-C)[23] and phospholipids[24] were analyzed.

2.7. Statistical analysis

The data were analyzed using Student's t-test statistical methods. For the statistical tests, P values less than 0.01 and 0.05 were taken as significant.

3. Result

3.1. Phytochemical constituents

The phytochemical screening of ethanol extract of M. malabathricum leaf revealed the presence of alkaloid, catechin, coumarin, flavonoid, phenol, saponin, steroid, tannin, terpenoid, sugar, glycoside and xanthoprotein.

3.2. Acute toxicity test

The extract was safe up to a dose of 2 000 mg/kg body weight. Behavior of the animals was closely observed for the first 8 h then at an interval of every 4 h during the next 48 h, the extract did not cause mortality on rats during 48 h observation or any behavioral change.

3.3. Body weight and fasting blood glucose

In the present study, alloxan induced diabetic rats showed significant (P<0.01) reduction in body weight. Administration of ethanol extract of M. malabathricum leaf (150 and 300 mg/kg) and glibenclamide (600 mg/kg) significantly (P<0.05) increased the body weight within 14 d (Table 1). Fasting blood glucose levels of the diabetic control rats were higher than those of normal rats. A significant (P<0.05) dose dependent decrease in blood glucose levels was observed in the diabetic treated group from an initial level of 232.14 mg/dL to the level of 144.36 mg/dL and from 213.12 mg/dL to 124.33 mg/dL after the treatment at a dose of 150 mg/kg and 300 mg/kg respectively for 14 d (Table 1).

Table 1. Effect of M. malabathricum leaf extract on the body weight and fasting blood glucose in normal, diabetic and diabetic treated rats.

Treatment groups	Mean initial body weight (g)	Mean final body weight (g)	Mean weight Gain (G↑)/loss (L↓) (g)	Fasting bloodglucose (mg/dL)
Treatment groups	Mean initial body weight (g)	Mean final body weight (g)	Mean weight Gain (G↑)/loss (L↓) (g)	Initial	Final (after 14 d)
Group I	189.54±5.11	197.65±6.36	8.12↑	69.88±1.92	73.95±1.64
Group II	192.63±8.24	173.94±5.24	18.69↓**	248.56±2.84	263.16±5.36
Group III	188.31±5.36	196.47±4.14	8.16↑^a	232.14±2.54	144.36±4.86^b
Group IV	184.51±5.33	194.93±4.38	10.42↑^a	213.12±5.28	124.33±4.37^b
Group V	196.58±9.34	216.42±7.39	19.84↑^a	229.66±6.16	104.53±4.35^b

Open in a new tab

Values are expressed as mean±SEM, n=5. **: P<0.05 comparison with normal control v.s. diabetic and drug treated; ^a: P<0.05 diabetic control v.s. drug treated; ^b: P<0.05 comparison with initial v.s. final.

3.4. Blood glucose level and other parameters

Table 2 shows the levels of blood glucose, serum insulin, urea, creatinine and glycosylated hemoglobin of normal, diabetic control and drug treated rats. There was a significant (P<0.01) increase blood glucose level in alloxan induced diabetic rats (Group II) when compared with normal rats (Group I). Administration of leaf extract of M. malabathricum (Groups III & IV) and glibenclamide (Group V) tended to bring the parameters significantly (P<0.05, P<0.01) towards the normal. Serum insulin level of diabetic control group was significantly (P<0.01) decreased when compared to normal control group (Group I). The extract and glibenclamide group of diabetic rats significantly (P<0.01) increased the serum insulin. A significant (P<0.05) elevation in urea and creatinine was observed in alloxan induced diabetic rats (Group II) when compared to control rats. The M. malabathricum extracts were administrated orally to diabetic rats for 14 d reversed the urea and creatinine level to near normal. Administration of ethanol extract of M. malabathricum leaf (300 mg/kg) and glibenclamide significantly (P<0.05) reduced HbA1c level compared to diabetic control rats.

Table 2. Effect of M. malabathricum leaf extracts on the serum insulin, glucose, urea, creatinine and HbA1c level of normal, diabetic induced and drug treated rats.

Treatment groups	Insulin (mIU/mL)	Glucose (mg/dL)	Urea (mg/dL)	Creatinine (mg/dL)	HbA1c (%)
Group I	21.830±1.130	73.81±3.54	12.05±1.04	0.73±0.12	4.61±0.52
Group II	9.190±0.948**	198.39±2.61**	29.63±1.85*	2.45±0.35*	9.89±0.25**
Group III	14.300±1.670^a	134.66±1.56^a	21.54±1.26	1.86±0.48	7.26±0.76^ns
Group IV	18.510±1.250^c	114.51±1.84^c	14.45±1.38	1.29±0.15	5.16±0.81^a
Group V	19.730±1.090^c	109.38±1.84^c	13.05±1.56^a	1.05±0.11^a	5.21±0.62^a

Open in a new tab

Values are expressed as mean±SEM, n=5. *: comparison made between normal control to diabetic control and drug treated groups; *: P<0.05, **: P<0.01; ^a: comparison made between diabetic control to drug treated groups; ^a: P<0.05, ^c: P<0.01; ns: not significant.

3.5. Biochemical parameters

The level of total protein, albumin, globulin and liver marker enzymes such as SGPT, SGOT and ALP in the serum of diabetic rats are presented in Table 3. Significant reductions in serum protein, albumin and globulin were observed in alloxan induced diabetic rats (Group II) when compared to control rats (Group I). On administration of ethanol extract of M. malabathricum leaf to the diabetic rats, protein albumin and globulin levels were found to be restored in normal. Also, the SGPT, SGOT and ALP levels were elevated significantly in alloxan induced diabetic rats compared to control rats. Both the doses of M. malabathricum leaf extracts and glibenclamide treatment significantly reduced above parameters compared to diabetic control rats.

Table 3. Effect of M. malabathricum leaf extracts on the serum protein, albumin, globulin, SGPT, SGOT and ALP level of normal, diabetic induced, and drug treated rats.

Treatment groups	Protein (g/dL)	Albumin (g/dL)	Globulin (g/dL)	SGPT (µ/L)	SGOT (µ/L)	ALP (µ/L)
Group I	7.93±0.16	4.63±0.14	3.30±0.11	18.53±1.62	20.16±1.33	184.93±3.65
Group II	6.02±0.19*	3.84±0.21*	2.18±0.24	97.18±3.54*	89.25±1.91*	226.16±4.84*
Group III	6.96±0.15^a	4.12±0.11	2.84±0.14	38.56±1.26	49.66±1.76	204.08±4.56^a
Group IV	8.26±0.65^a	4.86±0.53	3.40±0.52	27.59±1.84	30.51±1.94	191.56±2.89^a
Group V	7.96±0.38^ns	4.03±0.45	3.93±0.24	21.94±1.12	25.88±1.65	173.94±2.16^a

Open in a new tab

Values are expressed as mean±SEM, n=5. *: comparison made between normal control to diabetic control and drug treated groups; *: P<0.05; ^a: comparison made between diabetic control to drug treated groups; ^a: P<0.05; ns: not significant.

3.6. Lipid profiles

Table 4 shows the levels of TC, TG, LDL-C, VLDL-C, HDL-C and phospholipid in the serum of diabetic rats showed significantly (P<0.01) increased serum lipid profiles except HDL-C when compared with normal rats. The ethanol extract of M. malabathricum leaf treated rats showed a significant (P<0.01, P<0.05) decrease in the content of lipid profiles when compared with diabetic induced rats. Similarly HDL-C level decreased in alloxan induced diabetic rats when compared with normal rats. Administration of ethanol extract of M. malabathricum leaf and glibenclamide to the diabetic rats. HDL-C level was found to be restored to normal.

Table 4. Effect of M. malabathricum leaf extracts on the serum lipid profile of normal, diabetic induced, and drug treated rats.

Treatment groups	TC (mg/dL)	TG (mg/dL)	HDL (mg/dL)	LDL-C (mg/dL)	V-LDL (mg/dL)	Phospholipid (mg/dL)
Group I	103.34±2.18	93.61±1.64	42.98±2.16	41.64±1.32	18.72±1.03	159.97±3.51
Group II	214.26±4.76**	198.16±4.27**	26.36±1.65**	148.27±3.68**	39.63±1.26*	258.69±5.33**
Group III	164.13±2.48^c	156.31±1.74^c	31.14±2.14^a	96.64±1.34^a	34.44±1.34^a	224.36±2.36^a
Group IV	141.65±2.27^c	136.18±1.13^c	36.39±2.31^a	78.02±1.16^c	27.24±1.48^a	194.06±2.17^a
Group V	119.57±1.21^c	124.74±2.68^c	23.54±1.88	71.08±1.21^c	24.95±1.23^a	174.41±1.92^c

Open in a new tab

Values are expressed as mean±SEM, n=5. *: Comparison made between normal control to diabetic control and drug treated groups; *: P<0.05, **: P<0.01; ^a: comparison made between diabetic control to drug treated groups; ^a: P<0.05; ^c: P<0.01; ns: not significant.

4. Discussion

Diabetes mellitus is one of the most familiar chronic diseases associated with carbohydrate metabolism. It is also an indication of co-morbidities such as obesity, hypertension and hyperlipidemia which are metabolic complications of both clinical and experimental diabetes. Despite the fact that diabetes mellitus has high prevalence, morbidity, and mortality globally; it is regarded as a non curable but controllable disease. Different synthetic drugs, plant remedies and dietary modification play an efficient role in the reduction of the suffering that it causes. The potential role of medicinal plants as hypoglycemic agents has been reviewed by several researchers[25],[26].

Pancreas is the primary organ involved in sensing the organism's dietary and energetic states via glucose concentration in the blood and in response to elevated blood glucose, insulin is secreted.

Alloxan is one of the usual substances used for the induction of diabetes mellitus apart from streptozotocin. Alloxan has a destructive effect on the beta cells of the pancreas.

Alloxan causes a massive reduction in insulin release by the destruction of β-cells of the islets of langherhans, thereby inducing hyperglycemia. Insulin deficiency leads to various metabolic alterations in the animals viz. increased cholesterol, increased levels of alkaline phosphate and transaminases[27],[28].

In diabetic condition, elevated blood glucose, reduction in body weight, polyuria, polydipsia and polyphagia are commonly observed. In the present study, induction of diabetes by alloxan produced increase in blood glucose level, decrease in body weight and polyuria. In diabetic rats, observed reduction in body weight was possible due to catabolism of fats and protein[29]. The administration of ethanol extract of M. malabathricum leaf improves body weight compared to diabetic control rats which indicates preventive effect of M. malabathricum on degradation of structural proteins. The increase in blood glucose level after alloxan administration may be due to insulin deficiency or resistance state in diabetic rats. Administration of ethanol extract of M. malabathricum leaf significantly reduced blood glucose level in diabetic rats which represents reversal of insulin resistance or increasing insulin secretion possibly by regeneration of damaged pancreatic β-cells in alloxan-induced diabetic rats[30]. Earlier, many plants have been studied for their hypoglycemic and insulin release stimulatory effects[31]–[36].

In diabetes, elevated levels of serum urea and creatinine are observed which may be due to renal damage caused by abnormal glucose regulation or elevated glucose and glycosylated protein tissue levels[37]. In present study, significant increase in serum urea and creatinine levels were observed in diabetic rats compared to normal control rats which indicate impaired renal function in diabetic rats. The treatment with ethanol extract of M. malabathricum lowered the above parameters significantly compared to diabetic control rats and it showed protective effect of ethanol extract of M. malabathricum on the kidneys.

In diabetes, HbA1c is considered as a diagnostic marker and helps to know about degree of protein glycation, long-term blood sugar level and correlation of diabetes associated complications[38],[39]. HbA1c has been found to be increased over a long period of time in diabetes. During diabetes, the excess of glucose present in blood reacts with haemoglobin to form glycosylated haemoglobin[40]. The rate of glycation is proportional to the concentration of blood glucose. In present study, alloxan induced diabetic rats showed significant increase (P<0.01) HbA1c level compared with normal rats. The ethanol extract of M. malabathricum whole plant treated rats showed a significant decrease (P<0.05) in the content of glycosylated haemoglobin that could be due to an improvement in glycemic status.

In diabetic condition, occurrence of reduction in protein and albumin may be due to proteinuria, albuminuria or increased protein catabolism, which are clinical markers in diabetic nephropathy[41]. The protein and albumin level was reduced after the induction of diabetes and treatment of ethanol extract of M. malabathricum increased both levels considerably in diabetic rats towards normal level. This action possibly is through increase in the insulin mediated amino acid uptake, enhancement of protein synthesis and/or inhibition of protein degradation[42]. Also, increased serum SGOT, SGPT and ALP levels were reported in diabetes and it may be due to liver dysfunction[43]. In this study, increased level of SGOT, SGPT and ALP was observed in alloxan-induced diabetic rats which may have occurred by leakage of enzymes from the liver cytosol into the blood stream; it represents the toxicity of alloxan on liver. Diabetic rats treated with ethanol extract of M. malabathricum leaf significantly reduced both enzyme levels which represents the protective action of ethanol extract of M. malabathricum leaf in diabetic condition.

The most common lipid abnormalities in diabetes are hypertriglyceridemia and hypercholesterolemia[44]. The abnormal high concentrations of serum lipids in diabetic animals are mainly due to an increased mobilization of free fatty acids from peripheral fat depots[45]. In the present study, significantly increased levels of serum TC, TG, V-LDL and LDL as well as marked reduction in serum HDL level in diabetic rats. Administration of both the doses of ethanol extract of M. malabathricum leaf decreased levels of TC, LDL, V-LDL and TG levels as well as increased the level of HDL in diabetic rats. The above action could be beneficial in preventing diabetic complications such as coronary heart diseases and atherosclerosis in diabetic condition. Increased phospholipids levels in serum were reported by Anitha et al. in alloxan induced diabetic rats[46]. Administration of ethanol extract of M. malabathricum leaf glibenclamide decreased the levels of phospholipids.

In the present study, the administration of M. malabathricum leaf extracts to alloxan induced hyperglycemic rats demonstrated prominent reduction in blood sugar level, normalization of serum biochemical profile including lipid content, as compared to alloxan control rats. The phytochemical analysis has shown the presence of potent phytochemicals such as flavonoids, terpenoids, glycosides, steroids, saponin and phenols. Several authors reported that flavonoids, steroids/terpenoids, phenolic acids are known to be bioactive antidiabetic principles[47],[46]. Flavonoids are known to regenerate the damaged beta cells in the alloxan induced diabetic rats and acts as insulin secretagogues[48]. In the present study, the phytochemical analysis of ethanol extract of M. malabathricum leaf clearly prints out the presence of above said active principles. The preliminary investigation on the antihyperglycemic, antihyperlipidaemic and antioxidant efficacy of ethanol extract of M. malabathricum leaf will be significant to proceed further in this path for the isolation of active principles responsible for the antidiabetic activity.

Acknowledgments

The authors are thankful to Dr. R. Sampathraj, Honorary Director, Dr. Samsun Clinical Research Laboratory, Tirupur, for providing necessary facilities to carry out this work. The second author, V. R. Mohan gratefully acknowledges and expresses his sincere thanks to University Grants Commission, New Delhi for providing financial assistance [Grant No. F39-429/2011 (HRP)] dated 7 Jan 2011.

Comments

Background

Diabetes mellitus is still not completely curable by current antidiabetic drugs. Insulin therapy is the only satisfactory approach in diabetes mellitus, even though it has several drawbacks such as insulin resistance, anorexia, brain atrophy and fatty liver in chronic treatment. Treatment of type 2 diabetes mellitus patients with sulfonylureas and biguanides is always associated with side effects. So, herbal drugs are gaining popularity in the treatment of diabetes mellitus. The major merits of herbal medicines seem to be their efficacy, low incidence of side effects, and low cost. The paper is on analytical report of M. malabathricum leaf ethanolic extract. Relevant established protocol were used to analyse the antidiabetic and antihyperlipidaemic activity of ethanolic extract of the plant.

Research frontiers

Many traditional plant treatments for diabetes are used through out the world. Plant drugs and herbal formulations are frequently considered to be less toxic and free from side effects than synthetic one. Based on the WHO recommendations, hypoglycemic agents of plant origin used in traditional medicine are important.

Related Reports

Similar work has been done earlier in other plants using the same methodology.

Innovations and breakthroughs

The present study indicates that ethanolic extract of M. malabathricum leaf decreased the blood glucose levels in diabetic rats and increased the insulin level.

Applications

The results of this study give scientific credibility to the use of the plant M. malabathricum leaf in the treatment of many diabetics.

Peer review

This a good study in which the authors validated that, M. malabathricum leaf is a potential antidiabetic drug that may be used for maintaining traditional use.

Footnotes

Foundation Project: Supported by University Grants Commission, New Delhi [Grant No. F39-429/2011 (HRP)].

Conflict of interest statement: We declare that we have no conflict of interest.

References

1.Eseyin O, Ebong P, Eyong E, Awofisayo O, Agboke A. Effect of Telfairia occidentalis on oral glucose tolerance in rats. Afr J Pharm Pharmacol. 2010;4:368–372. [Google Scholar]
2.Patel DK, Prasad SK, Kumar R, Hemalatha S. An overview on antidiabetic medicinal plants having insulin mimetic property. Asian Pac J Trop Biomed. 2012;2:320–330. doi: 10.1016/S2221-1691(12)60032-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
3.Rajan M, Kumar VK, Kumar PS, Swathi KR, Haritha S. Antidiabetic, antihyperlipidaemic and hepatoprotective activity of methanolic extract of Ruellia tuberose Linn. leaves in normal and alloxan induced diabetes. J Chem Pharm Res. 2012;4:2860–2868. [Google Scholar]
4.Rajasekar V, Kirbanandan S, Lakshmi BS. Assessment of antidiabetic activity of Syzygium jambolanum using in vitro model. Am J Infect Dis. 2010;5:99–105. [Google Scholar]
5.Malviya N, Jain S, Malviya S. Antidiabetic potential of medicinal plants. Acta Pol Pharm. 2010;67:113–118. [PubMed] [Google Scholar]
6.Dangi KS, Mishra SN. Antihyperglycemic, antioxidant and hypolipidemic effect of Capparis aphylla stem extracts in streptozotocin induced diabetic rats. Biol Med. 2010;2:35–44. [Google Scholar]
7.Sunilson JA, Anandarajagopal K, Kumari AV, Mohan S. Antidiarrhoeal activity of leaves of Melastoma malabathricum. Indian J Pharm Sci. 2009;71:691–695. doi: 10.4103/0250-474X.59556. [DOI] [PMC free article] [PubMed] [Google Scholar]
8.Brinda P, Sasikala P, Purushothaman KK. Pharmacognostic studies on merugan kizhangu. Bull Med Ethnobot Res. 1981;3:84–96. [Google Scholar]
9.Lala PK. Lab manuals of pharmacognosy. Kolkata: CSI Publishers and Distributers; 1993. [Google Scholar]
10.Organisation for Economic cooperation and Development . Paris: OECD; 2002. OECD guidelines for the testing of chemicals: acute oral toxicity - acute toxic class method. [Online] Available from: http://www.oecd-ilibrary.org/docserver/download/9742301e.pdf?expires=1394073831&id=id&accname=guest&checksum=7DD1F36B2AD3F83470793BFD79E060AF [Accessed on 20th January, 2014] [Google Scholar]
11.Nagappa AN, Thakurdesai PA, Venkat Rao N, Sing J. Antidiabetic activity of Terminalia catappa Linn. fruits. J Ethnopharmacol. 2003;88:45–50. doi: 10.1016/s0378-8741(03)00208-3. [DOI] [PubMed] [Google Scholar]
12.Sasaki T, Masty S, Sonae A. Effect of acetic acid concentration on the colour reaction in the o-toluidine boric acid method for blood glucose estimation. Rinsho Kagaku. 1972;1:346–353. [Google Scholar]
13.Anderson L, Dinesen B, Jørgonsen PN, Poulsen F, Røder ME. Enzyme immune assay for intact human insulin in serum or plasma. Clin Chem. 1993;39:578–582. [PubMed] [Google Scholar]
14.Varley H. Practical clinical biochemistry. Chennai: Arnold Heinemann Publication Pvt. Ltd; 1976. p. 452. [Google Scholar]
15.Owen JA, Iggo JB, Scangrett FJ, Steward IP. The determination of creatinine in plasma or serum, and in urine - a critical examination. Biochem J. 1954;58:426–437. doi: 10.1042/bj0580426. [DOI] [PMC free article] [PubMed] [Google Scholar]
16.Karunanayake EH, Chandrasekharan NV. An evaluation of a colorimetric procedure for the estimation of glycosylated haemoglobin and establishment of reference values for Sri Lanka. J Natl Sci Counc Sri Lanka. 1985;13:235–258. [Google Scholar]
17.Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin's phenol reagent. J Biol Chem. 1951;193:265–275. [PubMed] [Google Scholar]
18.Reitman S, Frankel SA. A colorimetric method for the determination of serum glutamic oxaloacetic and glutamic pyruvic transaminases. Am J Clin Pathol. 1957;28:56–63. doi: 10.1093/ajcp/28.1.56. [DOI] [PubMed] [Google Scholar]
19.King EJ, Armstrong AR. A convenient method for determining serum and bile phosphatase activity. Can Med Assoc J. 1934;31:376–381. [PMC free article] [PubMed] [Google Scholar]
20.Parekh AC, Jung DH. Cholesterol determination with ferric acetate, uranium acetate and sulphuric acid, ferrous sulphate reagent. Anal Chem. 1970;42:1423–1427. [Google Scholar]
21.Rice EW. Triglycerides in serum. In: Roderick MP, editor. Standard methods of clinical chemistry. 9th ed. New York: Academic Press; 1970. pp. 215–222. [Google Scholar]
22.Friedwald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultra centrifuge. Clin Chem. 1972;18:499–502. [PubMed] [Google Scholar]
23.Warnick GR, Nguyan T, Albers AA. Comparison of improved precipitation methods for quantification of high density lipoprotein cholesterol. Clin Chem. 1985;31:217–222. [PubMed] [Google Scholar]
24.Takayama M, Itoh S, Nagasaki T, Tanimizu I. A new enzymatic method for determination of serum phospholipids. Clin Chem Acta. 1977;79:93–98. doi: 10.1016/0009-8981(77)90465-x. [DOI] [PubMed] [Google Scholar]
25.Tripathi AK, Bhoyar PK, Baheti JR, Biyaani DM, Khalique M, Kothmire MS, et al. Herbal antidiabetics: a review. Int J Res Pharm Sci. 2011;2:30–37. [Google Scholar]
26.Kavishankar GB, Lakshmidevi N, Muthy SM, Prakash HS, Niranjana SR. Diabetes and medicinal plants - a review. Int J Pharm Biomed Sci. 2011;2:65–80. [Google Scholar]
27.Sharma VK, Kumar S, Patel HJ, Hugar S. Hypoglycemic activity of Ficus glomerata in alloxan induced diabetic rats. Int J Pharm Sci Rev Res. 2010;1:18–22. [Google Scholar]
28.Bhatt NM, Barua S, Gupta S. Protective effect of Enicostemma littorale Blume on rat model of diabetic neuropathy. Am J Infect Dis. 2009;5:106–112. [Google Scholar]
29.Veeramani C, Pushpavalli G, Pugalendi KV. Antihyperglycaemic effect of Cardiospermum halicacabum Linn. leaf extract on streptozotocin induced diabetic rats. J Appl Biomed. 2008;6:19–26. doi: 10.1515/jbcpp.2010.21.2.107. [DOI] [PubMed] [Google Scholar]
30.Sezik E, Aslan M, Yesilada E, Ito S. Hypoglycaemic activity of Gentiana olivieri and isolation of the active constituent through bioassay-directed fractionation techniques. Life Sci. 2005;76:1223–1238. doi: 10.1016/j.lfs.2004.07.024. [DOI] [PubMed] [Google Scholar]
31.Pattabiraman K, Muthukumaran P. Antidiabetic and antioxidant activity of Morinda tinctoria Roxb. fruits extract in streptozotocin-induced diabetic rats. Asian J Pharm Tech. 2011;1:34–39. [Google Scholar]
32.Maruthupandian A, Mohan VR. Antidiabetic, antihyperlipidaemic and antioxidant activity of Pterocarpus marsupian Roxb. in alloxan induced diabetic rats. Int J PharmTech. 2011;3:1681–1687. [Google Scholar]
33.Shanmugasundaram R, Devi VK, Soris PT, Maruthupandian A, Mohan VR. Antidiabetic, antihyperlipidaemic and antioxidant activity of Senna auriculata (L.) Roxb. leaves in alloxan induced diabetic rats. Int J PharmTech Res. 2011;3:747–756. [Google Scholar]
34.Kala SM, Tresina PS, Mohan VR. Antioxidant, antihyperlipidaemic and antidiabetic activity of Eugenia floccosa Bedd. leaves in alloxan induced diabetic rats. J Basic Clin Pharmacy. 2012;3:235–240. doi: 10.4103/0976-0105.103831. [DOI] [PMC free article] [PubMed] [Google Scholar]
35.Kala SM, Tresina PS, Mohan VR. Antioxidant, antihyperlipidaemic and antidiabetic activity of Eugenia singamattina Bedd. leaves in alloxan induced diabetic rats. Int J Pharm Pharm Sci. 2012;4:412–416. doi: 10.4103/0976-0105.103831. [DOI] [PMC free article] [PubMed] [Google Scholar]
36.Shajeela PS, Kalpanadevi V, Mohan VR. Potential antidiabetic, hypolipidaemic and antioxidant effects of Nymphaea pubercens extract in alloxan induced diabetic rats. J Appl Pharm Sci. 2012;2:83–88. [Google Scholar]
37.Lal SS, Sukla Y, Singh A, Andriyas EA, Lall AM. Hyperuricemia, high serum urea and hypoproteinemia are are the risk factor for diabetes. Asian J Med Sci. 2009;1:33–34. [Google Scholar]
38.Deguchi Y, Miyazaki K. Anti-hyperglycemic and anti-hyperlipidemic effects of guava leaf extract. Nutr Metab. 2010;7:9. doi: 10.1186/1743-7075-7-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
39.Lanjhiyana S, Garabadu D, Ahirwar D, Bigoniya P, Chandrana A, Chandrapatra K, et al. Antidiabetic activity of methanolic extract of stem bark of Elaeodendron glaucum Pers. in alloxanized rat model. Adv Appl Sci Res. 2011;2:47–62. [Google Scholar]
40.Alagammal M, Nishanthini A, Mohan VR. Antihyperglycemic and antihyperlipidaemic effect of Polygala rosmarinifolia Wright & Arn on alloxan induced diabetic rats. J Appl Pharm Sci. 2012;2:143–148. [Google Scholar]
41.Kaleem M, Medha P, Ahmed QU, Asif M, Bano B. Beneficial effects of Annona squamosa extract in streptozotocin-induced diabetic rats. Singapore Med J. 2008;49:800–804. [PubMed] [Google Scholar]
42.Ramachandran S, Naveen KR, Rajinikanth B, Akbar M, Rajasekaran A. Antidiabetic, antihyperlipidemic and in vivo antioxidant potential of aqueous extract of Anogeissus latifolia bark in type 2 diabetic rats. Asian J Pac Trop Dis. 2012;2(Suppl 2):S596–S602. [Google Scholar]
43.Rao GM, Morghom LO, Kabur MN, Ben Mohmud BM, Ashibani K. Serum glutamic oxaloacetic transaminase (GOT) and glutamate pyruvate transaminase (GPT) levels in diabetes mellitus. Indian J Med Sci. 1989;43:118–121. [PubMed] [Google Scholar]
44.al-Shamaony L, al-Khazraji SM, Twaij HA. Hypoglycaemic effect of Artemisia herba alba II. Effect of a valuable extract on some blood parameters in diabetic animals. J Ethnopharmacol. 1994;43:167–171. doi: 10.1016/0378-8741(94)90038-8. [DOI] [PubMed] [Google Scholar]
45.Al-Logmani AS, Zari TA. Effects of Nigella sativa L. and Cinnamomum zeylanicum Blume oils on some physiological parameters in streptozotocin-induced diabetic rats. Bol Latinoam Caribe Plant Med Aromat. 2009;8:86–96. [Google Scholar]
46.Anitha M, Rajalakshmi K, Muthukumarasamy S, Mohan VR. Antihyperglycemic, antihyperlipidaemic and antioxidant ativity of Cynoglossum zeylanicum (Vahl Ex Hornem) Thurnb Ex lehrn in alloxan induced diabetic rats. Int J Pharm Pharm Sci. 2012;4:490–495. [Google Scholar]
47.Alagammal M, Rajalakshmi K, Mohan VR. Antidiabetic and antihyperlipidaemic activity of Polygala chinensis L. whole plant in alloxan induced diabetic rats. Int J Chem Pharm Sci. 2012;3:37–44. [Google Scholar]
48.Alagammal M, Agnel RA, Mohan VR. Antidiabetic and antihyperlipidaemic effect of Polygala javana DC on alloxan induced diabetic rats. Int Res J Pharm. 2012;3:231–234. [Google Scholar]

[b1] 1.Eseyin O, Ebong P, Eyong E, Awofisayo O, Agboke A. Effect of Telfairia occidentalis on oral glucose tolerance in rats. Afr J Pharm Pharmacol. 2010;4:368–372. [Google Scholar]

[b2] 2.Patel DK, Prasad SK, Kumar R, Hemalatha S. An overview on antidiabetic medicinal plants having insulin mimetic property. Asian Pac J Trop Biomed. 2012;2:320–330. doi: 10.1016/S2221-1691(12)60032-X. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b3] 3.Rajan M, Kumar VK, Kumar PS, Swathi KR, Haritha S. Antidiabetic, antihyperlipidaemic and hepatoprotective activity of methanolic extract of Ruellia tuberose Linn. leaves in normal and alloxan induced diabetes. J Chem Pharm Res. 2012;4:2860–2868. [Google Scholar]

[b4] 4.Rajasekar V, Kirbanandan S, Lakshmi BS. Assessment of antidiabetic activity of Syzygium jambolanum using in vitro model. Am J Infect Dis. 2010;5:99–105. [Google Scholar]

[b5] 5.Malviya N, Jain S, Malviya S. Antidiabetic potential of medicinal plants. Acta Pol Pharm. 2010;67:113–118. [PubMed] [Google Scholar]

[b6] 6.Dangi KS, Mishra SN. Antihyperglycemic, antioxidant and hypolipidemic effect of Capparis aphylla stem extracts in streptozotocin induced diabetic rats. Biol Med. 2010;2:35–44. [Google Scholar]

[b7] 7.Sunilson JA, Anandarajagopal K, Kumari AV, Mohan S. Antidiarrhoeal activity of leaves of Melastoma malabathricum. Indian J Pharm Sci. 2009;71:691–695. doi: 10.4103/0250-474X.59556. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b8] 8.Brinda P, Sasikala P, Purushothaman KK. Pharmacognostic studies on merugan kizhangu. Bull Med Ethnobot Res. 1981;3:84–96. [Google Scholar]

[b9] 9.Lala PK. Lab manuals of pharmacognosy. Kolkata: CSI Publishers and Distributers; 1993. [Google Scholar]

[b10] 10.Organisation for Economic cooperation and Development . Paris: OECD; 2002. OECD guidelines for the testing of chemicals: acute oral toxicity - acute toxic class method. [Online] Available from: http://www.oecd-ilibrary.org/docserver/download/9742301e.pdf?expires=1394073831&id=id&accname=guest&checksum=7DD1F36B2AD3F83470793BFD79E060AF [Accessed on 20th January, 2014] [Google Scholar]

[b11] 11.Nagappa AN, Thakurdesai PA, Venkat Rao N, Sing J. Antidiabetic activity of Terminalia catappa Linn. fruits. J Ethnopharmacol. 2003;88:45–50. doi: 10.1016/s0378-8741(03)00208-3. [DOI] [PubMed] [Google Scholar]

[b12] 12.Sasaki T, Masty S, Sonae A. Effect of acetic acid concentration on the colour reaction in the o-toluidine boric acid method for blood glucose estimation. Rinsho Kagaku. 1972;1:346–353. [Google Scholar]

[b13] 13.Anderson L, Dinesen B, Jørgonsen PN, Poulsen F, Røder ME. Enzyme immune assay for intact human insulin in serum or plasma. Clin Chem. 1993;39:578–582. [PubMed] [Google Scholar]

[b14] 14.Varley H. Practical clinical biochemistry. Chennai: Arnold Heinemann Publication Pvt. Ltd; 1976. p. 452. [Google Scholar]

[b15] 15.Owen JA, Iggo JB, Scangrett FJ, Steward IP. The determination of creatinine in plasma or serum, and in urine - a critical examination. Biochem J. 1954;58:426–437. doi: 10.1042/bj0580426. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b16] 16.Karunanayake EH, Chandrasekharan NV. An evaluation of a colorimetric procedure for the estimation of glycosylated haemoglobin and establishment of reference values for Sri Lanka. J Natl Sci Counc Sri Lanka. 1985;13:235–258. [Google Scholar]

[b17] 17.Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin's phenol reagent. J Biol Chem. 1951;193:265–275. [PubMed] [Google Scholar]

[b18] 18.Reitman S, Frankel SA. A colorimetric method for the determination of serum glutamic oxaloacetic and glutamic pyruvic transaminases. Am J Clin Pathol. 1957;28:56–63. doi: 10.1093/ajcp/28.1.56. [DOI] [PubMed] [Google Scholar]

[b19] 19.King EJ, Armstrong AR. A convenient method for determining serum and bile phosphatase activity. Can Med Assoc J. 1934;31:376–381. [PMC free article] [PubMed] [Google Scholar]

[b20] 20.Parekh AC, Jung DH. Cholesterol determination with ferric acetate, uranium acetate and sulphuric acid, ferrous sulphate reagent. Anal Chem. 1970;42:1423–1427. [Google Scholar]

[b21] 21.Rice EW. Triglycerides in serum. In: Roderick MP, editor. Standard methods of clinical chemistry. 9th ed. New York: Academic Press; 1970. pp. 215–222. [Google Scholar]

[b22] 22.Friedwald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultra centrifuge. Clin Chem. 1972;18:499–502. [PubMed] [Google Scholar]

[b23] 23.Warnick GR, Nguyan T, Albers AA. Comparison of improved precipitation methods for quantification of high density lipoprotein cholesterol. Clin Chem. 1985;31:217–222. [PubMed] [Google Scholar]

[b24] 24.Takayama M, Itoh S, Nagasaki T, Tanimizu I. A new enzymatic method for determination of serum phospholipids. Clin Chem Acta. 1977;79:93–98. doi: 10.1016/0009-8981(77)90465-x. [DOI] [PubMed] [Google Scholar]

[b25] 25.Tripathi AK, Bhoyar PK, Baheti JR, Biyaani DM, Khalique M, Kothmire MS, et al. Herbal antidiabetics: a review. Int J Res Pharm Sci. 2011;2:30–37. [Google Scholar]

[b26] 26.Kavishankar GB, Lakshmidevi N, Muthy SM, Prakash HS, Niranjana SR. Diabetes and medicinal plants - a review. Int J Pharm Biomed Sci. 2011;2:65–80. [Google Scholar]

[b27] 27.Sharma VK, Kumar S, Patel HJ, Hugar S. Hypoglycemic activity of Ficus glomerata in alloxan induced diabetic rats. Int J Pharm Sci Rev Res. 2010;1:18–22. [Google Scholar]

[b28] 28.Bhatt NM, Barua S, Gupta S. Protective effect of Enicostemma littorale Blume on rat model of diabetic neuropathy. Am J Infect Dis. 2009;5:106–112. [Google Scholar]

[b29] 29.Veeramani C, Pushpavalli G, Pugalendi KV. Antihyperglycaemic effect of Cardiospermum halicacabum Linn. leaf extract on streptozotocin induced diabetic rats. J Appl Biomed. 2008;6:19–26. doi: 10.1515/jbcpp.2010.21.2.107. [DOI] [PubMed] [Google Scholar]

[b30] 30.Sezik E, Aslan M, Yesilada E, Ito S. Hypoglycaemic activity of Gentiana olivieri and isolation of the active constituent through bioassay-directed fractionation techniques. Life Sci. 2005;76:1223–1238. doi: 10.1016/j.lfs.2004.07.024. [DOI] [PubMed] [Google Scholar]

[b31] 31.Pattabiraman K, Muthukumaran P. Antidiabetic and antioxidant activity of Morinda tinctoria Roxb. fruits extract in streptozotocin-induced diabetic rats. Asian J Pharm Tech. 2011;1:34–39. [Google Scholar]

[b32] 32.Maruthupandian A, Mohan VR. Antidiabetic, antihyperlipidaemic and antioxidant activity of Pterocarpus marsupian Roxb. in alloxan induced diabetic rats. Int J PharmTech. 2011;3:1681–1687. [Google Scholar]

[b33] 33.Shanmugasundaram R, Devi VK, Soris PT, Maruthupandian A, Mohan VR. Antidiabetic, antihyperlipidaemic and antioxidant activity of Senna auriculata (L.) Roxb. leaves in alloxan induced diabetic rats. Int J PharmTech Res. 2011;3:747–756. [Google Scholar]

[b34] 34.Kala SM, Tresina PS, Mohan VR. Antioxidant, antihyperlipidaemic and antidiabetic activity of Eugenia floccosa Bedd. leaves in alloxan induced diabetic rats. J Basic Clin Pharmacy. 2012;3:235–240. doi: 10.4103/0976-0105.103831. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b35] 35.Kala SM, Tresina PS, Mohan VR. Antioxidant, antihyperlipidaemic and antidiabetic activity of Eugenia singamattina Bedd. leaves in alloxan induced diabetic rats. Int J Pharm Pharm Sci. 2012;4:412–416. doi: 10.4103/0976-0105.103831. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b36] 36.Shajeela PS, Kalpanadevi V, Mohan VR. Potential antidiabetic, hypolipidaemic and antioxidant effects of Nymphaea pubercens extract in alloxan induced diabetic rats. J Appl Pharm Sci. 2012;2:83–88. [Google Scholar]

[b37] 37.Lal SS, Sukla Y, Singh A, Andriyas EA, Lall AM. Hyperuricemia, high serum urea and hypoproteinemia are are the risk factor for diabetes. Asian J Med Sci. 2009;1:33–34. [Google Scholar]

[b38] 38.Deguchi Y, Miyazaki K. Anti-hyperglycemic and anti-hyperlipidemic effects of guava leaf extract. Nutr Metab. 2010;7:9. doi: 10.1186/1743-7075-7-9. [DOI] [PMC free article] [PubMed] [Google Scholar]

[b39] 39.Lanjhiyana S, Garabadu D, Ahirwar D, Bigoniya P, Chandrana A, Chandrapatra K, et al. Antidiabetic activity of methanolic extract of stem bark of Elaeodendron glaucum Pers. in alloxanized rat model. Adv Appl Sci Res. 2011;2:47–62. [Google Scholar]

[b40] 40.Alagammal M, Nishanthini A, Mohan VR. Antihyperglycemic and antihyperlipidaemic effect of Polygala rosmarinifolia Wright & Arn on alloxan induced diabetic rats. J Appl Pharm Sci. 2012;2:143–148. [Google Scholar]

[b41] 41.Kaleem M, Medha P, Ahmed QU, Asif M, Bano B. Beneficial effects of Annona squamosa extract in streptozotocin-induced diabetic rats. Singapore Med J. 2008;49:800–804. [PubMed] [Google Scholar]

[b42] 42.Ramachandran S, Naveen KR, Rajinikanth B, Akbar M, Rajasekaran A. Antidiabetic, antihyperlipidemic and in vivo antioxidant potential of aqueous extract of Anogeissus latifolia bark in type 2 diabetic rats. Asian J Pac Trop Dis. 2012;2(Suppl 2):S596–S602. [Google Scholar]

[b43] 43.Rao GM, Morghom LO, Kabur MN, Ben Mohmud BM, Ashibani K. Serum glutamic oxaloacetic transaminase (GOT) and glutamate pyruvate transaminase (GPT) levels in diabetes mellitus. Indian J Med Sci. 1989;43:118–121. [PubMed] [Google Scholar]

[b44] 44.al-Shamaony L, al-Khazraji SM, Twaij HA. Hypoglycaemic effect of Artemisia herba alba II. Effect of a valuable extract on some blood parameters in diabetic animals. J Ethnopharmacol. 1994;43:167–171. doi: 10.1016/0378-8741(94)90038-8. [DOI] [PubMed] [Google Scholar]

[b45] 45.Al-Logmani AS, Zari TA. Effects of Nigella sativa L. and Cinnamomum zeylanicum Blume oils on some physiological parameters in streptozotocin-induced diabetic rats. Bol Latinoam Caribe Plant Med Aromat. 2009;8:86–96. [Google Scholar]

[b46] 46.Anitha M, Rajalakshmi K, Muthukumarasamy S, Mohan VR. Antihyperglycemic, antihyperlipidaemic and antioxidant ativity of Cynoglossum zeylanicum (Vahl Ex Hornem) Thurnb Ex lehrn in alloxan induced diabetic rats. Int J Pharm Pharm Sci. 2012;4:490–495. [Google Scholar]

[b47] 47.Alagammal M, Rajalakshmi K, Mohan VR. Antidiabetic and antihyperlipidaemic activity of Polygala chinensis L. whole plant in alloxan induced diabetic rats. Int J Chem Pharm Sci. 2012;3:37–44. [Google Scholar]

[b48] 48.Alagammal M, Agnel RA, Mohan VR. Antidiabetic and antihyperlipidaemic effect of Polygala javana DC on alloxan induced diabetic rats. Int Res J Pharm. 2012;3:231–234. [Google Scholar]

PERMALINK

Antidiabetic and antihyperlipidaemic activity of ethanol extract of Melastoma malabathricum Linn. leaf in alloxan induced diabetic rats

Karuppasamy Balamurugan

Antony Nishanthini

Veerabahu Ramasamy Mohan

Abstract

Objective

Methods

Results

Conclusions

1. Introduction

2. Materials and methods

2.1. Plant material

2.2. Preparation of plant extract for phytochemical screening and antidiabetic studies

2.3. Animals

2.4. Acute toxicity study

2.5. Induction of diabetes in experimental animal

2.6. Experimental design

2.6.1. Estimation of insulin, glucose, urea, creatinine and glycosylated haemoglobin

2.6.2. Estimation of protein, albumin, globulin, SGPT, SGOT, ALP

2.6.3. Estimation of lipids and lipoprotein

2.7. Statistical analysis

3. Result

3.1. Phytochemical constituents

3.2. Acute toxicity test

3.3. Body weight and fasting blood glucose

Table 1. Effect of M. malabathricum leaf extract on the body weight and fasting blood glucose in normal, diabetic and diabetic treated rats.

3.4. Blood glucose level and other parameters

Table 2. Effect of M. malabathricum leaf extracts on the serum insulin, glucose, urea, creatinine and HbA1c level of normal, diabetic induced and drug treated rats.

3.5. Biochemical parameters

Table 3. Effect of M. malabathricum leaf extracts on the serum protein, albumin, globulin, SGPT, SGOT and ALP level of normal, diabetic induced, and drug treated rats.

3.6. Lipid profiles

Table 4. Effect of M. malabathricum leaf extracts on the serum lipid profile of normal, diabetic induced, and drug treated rats.

4. Discussion

Acknowledgments

Comments

Background

Research frontiers

Related Reports

Innovations and breakthroughs

Applications

Peer review

Footnotes

References

ACTIONS

PERMALINK

RESOURCES

Similar articles

Cited by other articles

Links to NCBI Databases